Poster 1350 Tagarro CORTEEC id week 2016

Poster 1350 Tagarro CORTEEC id week 2016

[email protected]
+34606194888
Poster#1350
DEXAMETHASONEFORPARAPNEUMONICPLEURALEFFUSIONINCHILDRENA
RANDOMIZED,DOUBLEBLIND,PHASEIICLINICALTRIAL
AlfredoTagarro(HospitalInfantaSofia,SanSebasFándelosReyes.UniversidadEuropeadeMadrid),
OnbehalfofCORTEECStudyGroup
E.Otheo(H.RamónyCajal)F.Baquero(H.LaPaz),M.Navarro(H.GregorioMarañón),M.Ruiz(HdeGetafe),R.Velasco(C.H.de
Toledo),D.Moreno(H.CarlosHaya),M.Penín(H.PrínicipedeAsturias),P.Rojo(H.12deOctubre),DSanz(Universidad
EuropeadeMadrid),R.Madero(HospitalLaPaz)CORTEECStudyGroup.
1.AIMS
PRIMARY(EFFICACY)
ToinvesFgatewhetherDXM(0.25mg/kg/6hours;length:2days),alongwithanFbioFctherapydecreasedthe-metorecoveryofpleural
effusion,comparedtoplacebo.
SECONDARY
Complica-onsofdiseasefromthemomentofhospitalizaFonunFlday+30aeerdischarge
AdverseeventsafributabletosteroidsduringhospitalizaFon
2.METHODS
3.RESULTS
MulFcenterclinicaltrial,randomized,double-blind,placebo
controlled.Industry-independent.
4.RESULTS(Con-nued)
Secondaryendpoints
CONCLUSION
DexamethasonewasasafeandeffecFveadjunFvetherapyfordecreasingFmetorecoveryinchildrenwithpleuralinfecFon.
ThistrialprovidesabasisforalargeanddefiniFvetrialthatshouldbepoweredtoconfirmthefindings